It subsequently suppressed its targets such as TNFAIP1, p21, caspase 3 and SMAD4. MiR224 might regulate CRC growth by targeting p21 to modulate CRC proliferation and prognosis. This evidence concerns the gene SMAD4 and colorectal carcinoma.